Correlation between serum and salivary phenytoin concentrations in Thai epileptic children

Sahas Liamsuwan1, Ulailuk Jaiweerawattana

  • 1Division of Child Neurology, Queen Sirikit National Institute of Child Health, Department of Medical Services, Ministry of Public Health, College of Medicine, Rangsit University, Bangkok, Thailand. liamsuwan@hotmail.com

Insights

Saliva can effectively monitor phenytoin levels in Thai children with epilepsy, showing a strong correlation with serum levels. This offers a less invasive alternative to blood tests for managing medication dosages.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology
  • Biomarker Analysis

Background:

  • Epilepsy management in children requires precise drug level monitoring.
  • Phenytoin is a common antiepileptic drug, but blood collection can be challenging in pediatric patients.
  • Exploring alternative, less invasive methods for phenytoin monitoring is crucial.

Purpose of the Study:

  • To investigate the correlation between serum and salivary phenytoin concentrations in Thai epileptic children.
  • To establish predictive equations for phenytoin levels based on saliva samples.

Main Methods:

  • Studied Thai children (5-12 years) with epilepsy on phenytoin monotherapy.
  • Collected blood and saliva samples for phenytoin level measurement using fluorescence-polarization immunoassay.
  • Excluded patients with specific health conditions or poor compliance.

Main Results:

  • A close linear correlation (R=0.880, R²=0.967) was found between serum and salivary phenytoin levels.
  • Equations were derived to predict serum and salivary phenytoin levels from drug dosage.
  • Adverse drug reactions were observed in 6.6% of patients.

Conclusions:

  • Salivary phenytoin monitoring is a viable and highly correlated alternative to serum monitoring in Thai children.
  • This approach can simplify drug management, reduce patient distress, and improve adherence.
  • The derived equations can aid in adjusting phenytoin dosage regimens in clinical practice.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...